These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 10766347

  • 1. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM, Turunen M, Tyynelä K, Loimas S, Vainio P, Vanninen R, Vapalahti M, Bjerkvig R, Jänne J, Ylä-Herttuala S.
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K, Sandmair AM, Turunen M, Vanninen R, Vainio P, Kauppinen R, Johansson R, Vapalahti M, Ylä-Herttuala S.
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [Abstract] [Full Text] [Related]

  • 3. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Nov; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 4. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 6. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S.
    Cancer Gene Ther; 2000 Jun 15; 7(6):947-53. PubMed ID: 10880027
    [Abstract] [Full Text] [Related]

  • 7. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX, Ngo D, Brade AM, Klamut HJ.
    Cancer Gene Ther; 1999 Jun 15; 6(2):179-90. PubMed ID: 10195885
    [Abstract] [Full Text] [Related]

  • 8. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 15; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 15; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 10. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 15; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 11. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE, Yu HM, Liu RS, Lin M, Gelovani JG, Hwang JJ, Wei HJ, Deng WP.
    J Nucl Med; 2006 Jul 15; 47(7):1161-71. PubMed ID: 16818951
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD.
    J Neurosci Res; 1994 Nov 01; 39(4):506-11. PubMed ID: 7884826
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K, Loimas S, Wahlfors J, Alhava E, Jänne J.
    J Gene Med; 2000 Nov 01; 2(5):361-7. PubMed ID: 11045430
    [Abstract] [Full Text] [Related]

  • 14. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB, Nicholas T, Kruse CA.
    Cancer Gene Ther; 2002 Jan 01; 9(1):87-95. PubMed ID: 11916247
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS, Sabo P, Adman ET, Black ME.
    Gene Ther; 1999 Aug 01; 6(8):1415-26. PubMed ID: 10467366
    [Abstract] [Full Text] [Related]

  • 16. [Suicide gene therapy for glioma using HSV-tk/GCV system].
    Xu L, Ge K, Zheng Z.
    Zhonghua Zhong Liu Za Zhi; 1997 Sep 01; 19(5):353-7. PubMed ID: 10920915
    [Abstract] [Full Text] [Related]

  • 17. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
    Zhang XF, Ren ZY, Fang FD, Zuo J, Su CB, Wang RZ, Ma WB.
    Ai Zheng; 2002 May 01; 21(5):473-9. PubMed ID: 12452035
    [Abstract] [Full Text] [Related]

  • 18. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 19. Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.
    Yamamoto S, Suzuki S, Hoshino A, Akimoto M, Shimada T.
    Cancer Gene Ther; 1997 Nov 10; 4(2):91-6. PubMed ID: 9080117
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator.
    Yamaguchi T, Okada T, Takeuchi K, Tonda T, Ohtaki M, Shinoda S, Masuzawa T, Ozawa K, Inaba T.
    Gene Ther; 2003 Mar 10; 10(5):375-85. PubMed ID: 12601392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.